Net Cash Provided by (Used in) Operating Activities |
241K |
USD |
|
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-38.8K |
USD |
-122% |
Q4 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
10B |
shares |
0% |
Q1 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
4.28B |
shares |
+83.6% |
Q1 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
202K |
USD |
+40.5% |
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
136K |
USD |
+304% |
Q1 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
1.93M |
USD |
-11.2% |
Q1 2025 |
Q2 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q4 2024 |
Q1 2025 |
Operating Lease, Liability |
486K |
USD |
-33.4% |
Q1 2025 |
Q2 2025 |
Depreciation |
477 |
USD |
-56.9% |
Q4 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, to be Paid |
489K |
USD |
-33.7% |
Q1 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.93M |
USD |
-11.2% |
Q1 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q1 2025 |
Q2 2025 |
Amortization of Intangible Assets |
100K |
USD |
-82.2% |
Q1 2025 |
Q2 2025 |
Interest Expense |
10.3K |
USD |
|
Q3 2023 |
FY 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q2 2025 |